SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Napro Biotherap(npro)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
478 16 0 NPRO
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
478TESTJohn McCarthy-11/9/2003
4772003 - Investor Presentation - drug canidates secfilings.nasdaq.com NBT 287 InJohn McCarthy-11/3/2003
476chuck - I don't KNOW but if I had to guess the answer would be no. all theJohn McCarthy-9/23/2003
475john, technology review has an article on gene repair, 10/03 page 15. talks abocreddell-9/23/2003
474Their original work in mice - sciencedaily.com eurekalert.org the story behinJohn McCarthy-6/9/2003
473Abstract #1204 from ASGT June 8th by: lazbroker1 Long-Term Sentiment: Strong BJohn McCarthy-6/8/2003
472Press Release Source: NaPro BioTherapeutics, Inc. NaPro's Technology ExtenJohn McCarthy-6/8/2003
471The purpose of this post is to list somewhat similar articles by Kmiec (NPRO) anJohn McCarthy-3/13/2003
470GENE THERAPY: The Strange Case of Chimeraplasty Gary Taubes it.geocities.comJohn McCarthy-12/30/2002
469Sonus May Score With New Taxol Formula By Adam Feuerstein Senior Writer 09/18/John McCarthy-12/23/2002
468Press Release Source: CytoGenix Inc. CytoGenix Inc. and The University of TexaJohn McCarthy-11/26/2002
467<B>TGR - BUZZ</B><I>_WORDS.....(subject to errors of understanJohn McCarthy-9/22/2002
466<B><I>Gene Trial Links</I></B> <I>File Created On:John McCarthy-9/22/2002
465<B>BUZZ</B><I>_WORDS.....(subject to errors of understanding)&John McCarthy-9/22/2002
464library.usyd.edu.auJohn McCarthy-9/16/2002
463ncbi.nlm.nih.gov Saccharomyces cerevisiae ncbi.nlm.nih.gov ncbi.nlm.nih.gov John McCarthy-9/16/2002
462biz.yahoo.comJohn McCarthy-9/16/2002
461<B>Subject:TGR-Non Disease Specific</B> <I>(The following mateJohn McCarthy-9/15/2002
460<B>Subject:TGR-Non Disease Specific</B> <I>(The following mateJohn McCarthy-9/15/2002
459IGNORE - thru 2000 <B>Subject:Targeted Gene Therapy</B> <I>(TJohn McCarthy-9/14/2002
458John, great article. It seems that the success is gonna be dependent on the tarMark Morrow-9/11/2002
457Chimeraplasty Potential RESEARCH Chimeraplasty Potential As research advanceJohn McCarthy-9/10/2002
456Sickle Cell - Targeted Gene Repair - Advanced Progress Notes: (1) This study wJohn McCarthy-9/8/2002
455NAPRO - EUROPEAN PATENT - DELIVERY OF TAXANES Part 3 of 3 posts Part 3:<b&gJohn McCarthy-9/7/2002
454NAPRO - EUROPEAN PATENT - DELIVERY OF TAXANES Part 2 of 3 posts Part 2:<b&gJohn McCarthy-9/7/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News